Hemostasis, coagulation abnormalities, and liver disease

Carole L. Mackavey, Robert Hanks

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Coagulopathy-related bleeding events are a major concern in the management of acute and chronic liver disease. The liver attempts to maintain a balance between procoagulant and anticoagulant factors, and providers struggle with poor prognostic indicators to manage bleeding and critical complications. Subtle changes in patient presentation that may require extensive provider-directed interventions, such as blood transfusions, intravenous fluid management, mitigating possible sepsis, and evaluating appropriate pharmacologic treatment, are discussed.

Original languageEnglish
Pages (from-to)435-446
Number of pages12
JournalCritical Care Nursing Clinics of North America
Volume25
Issue number4
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Hemostasis
Liver Diseases
Hemorrhage
Blood Transfusion
Anticoagulants
Sepsis
Chronic Disease
Liver
Therapeutics

Keywords

  • Anticoagulants
  • Coagulation abnormalities
  • Fibrinolysis
  • Hemostasis
  • Liver disease
  • Procoagulants

ASJC Scopus subject areas

  • Critical Care

Cite this

Hemostasis, coagulation abnormalities, and liver disease. / Mackavey, Carole L.; Hanks, Robert.

In: Critical Care Nursing Clinics of North America, Vol. 25, No. 4, 12.2013, p. 435-446.

Research output: Contribution to journalArticle

Mackavey, Carole L. ; Hanks, Robert. / Hemostasis, coagulation abnormalities, and liver disease. In: Critical Care Nursing Clinics of North America. 2013 ; Vol. 25, No. 4. pp. 435-446.
@article{aa83df41aa7b4405b51396ca5d1b2204,
title = "Hemostasis, coagulation abnormalities, and liver disease",
abstract = "Coagulopathy-related bleeding events are a major concern in the management of acute and chronic liver disease. The liver attempts to maintain a balance between procoagulant and anticoagulant factors, and providers struggle with poor prognostic indicators to manage bleeding and critical complications. Subtle changes in patient presentation that may require extensive provider-directed interventions, such as blood transfusions, intravenous fluid management, mitigating possible sepsis, and evaluating appropriate pharmacologic treatment, are discussed.",
keywords = "Anticoagulants, Coagulation abnormalities, Fibrinolysis, Hemostasis, Liver disease, Procoagulants",
author = "Mackavey, {Carole L.} and Robert Hanks",
year = "2013",
month = "12",
doi = "10.1016/j.ccell.2013.09.001",
language = "English",
volume = "25",
pages = "435--446",
journal = "Critical Care Nursing Clinics of North America",
issn = "0899-5885",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Hemostasis, coagulation abnormalities, and liver disease

AU - Mackavey, Carole L.

AU - Hanks, Robert

PY - 2013/12

Y1 - 2013/12

N2 - Coagulopathy-related bleeding events are a major concern in the management of acute and chronic liver disease. The liver attempts to maintain a balance between procoagulant and anticoagulant factors, and providers struggle with poor prognostic indicators to manage bleeding and critical complications. Subtle changes in patient presentation that may require extensive provider-directed interventions, such as blood transfusions, intravenous fluid management, mitigating possible sepsis, and evaluating appropriate pharmacologic treatment, are discussed.

AB - Coagulopathy-related bleeding events are a major concern in the management of acute and chronic liver disease. The liver attempts to maintain a balance between procoagulant and anticoagulant factors, and providers struggle with poor prognostic indicators to manage bleeding and critical complications. Subtle changes in patient presentation that may require extensive provider-directed interventions, such as blood transfusions, intravenous fluid management, mitigating possible sepsis, and evaluating appropriate pharmacologic treatment, are discussed.

KW - Anticoagulants

KW - Coagulation abnormalities

KW - Fibrinolysis

KW - Hemostasis

KW - Liver disease

KW - Procoagulants

UR - http://www.scopus.com/inward/record.url?scp=84888050782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888050782&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2013.09.001

DO - 10.1016/j.ccell.2013.09.001

M3 - Article

VL - 25

SP - 435

EP - 446

JO - Critical Care Nursing Clinics of North America

JF - Critical Care Nursing Clinics of North America

SN - 0899-5885

IS - 4

ER -